Categories
All News

Vagus Nerve Stimulators Market Report- Statistical Analysis, Business Opportunity and Forecast 2025

ReportsnReports added a new report on The Vagus Nerve Stimulators (VNS) Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. In-depth study on the current state which focuses on the major drivers and restraints for the key players. Vagus Nerve Stimulators (VNS) Market Industry research report provides granular analysis of the market share, segmentation, revenue forecasts, geographic regions of the market and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Vagus Nerve Stimulators (VNS) Market.

Download FREE PDF sample of this Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2826313

Vagus Nerve Stimulators (VNS) Market Top Companies and Product Overview :-
Aucta Technologies Inc
Boston Scientific Corp
Cala Health Inc
CerboMed GmbH
Cyberonics Inc
DuoCure Ltd.

and more…

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Vagus Nerve Stimulators (VNS) pipeline products.

Scope of the Report-
– Extensive coverage of the Vagus Nerve Stimulators (VNS) under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Vagus Nerve Stimulators (VNS) and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry.

Get FLAT 20% Discount on this Report @

https://www.reportsnreports.com/purchase.aspx?name=2826313

Reasons to buy this Report-
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies.
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Identify and understand important and diverse types of Vagus Nerve Stimulators (VNS) under development
– Develop market-entry and market expansion strategies.
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
– In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Get FLAT 20% Discount on this Report @

Table of Contents in this Report-
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Vagus Nerve Stimulators (VNS) Overview 8
3 Products under Development 9
3.1 Vagus Nerve Stimulators (VNS) – Pipeline Products by Stage of Development 9
3.2 Vagus Nerve Stimulators (VNS) – Pipeline Products by Territory 10
3.3 Vagus Nerve Stimulators (VNS) – Pipeline Products by Regulatory Path 11
3.4 Vagus Nerve Stimulators (VNS) – Pipeline Products by Estimated Approval Date 12
3.5 Vagus Nerve Stimulators (VNS) – Ongoing Clinical Trials 13
4 Vagus Nerve Stimulators (VNS) – Pipeline Products under Development by Companies 14
4.1 Vagus Nerve Stimulators (VNS) Companies – Pipeline Products by Stage of Development 14
4.2 Vagus Nerve Stimulators (VNS) – Pipeline Products by Stage of Development 15
5 Vagus Nerve Stimulators (VNS) Companies and Product Overview 17
5.1 Aucta Technologies Inc Company Overview 17
5.1.1 Aucta Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Boston Scientific Corp Company Overview 20
5.2.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Cala Health Inc Company Overview 24
5.3.1 Cala Health Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 CerboMed GmbH Company Overview 25
5.4.1 CerboMed GmbH Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Cyberonics Inc Company Overview 26
5.5.1 Cyberonics Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 DuoCure Ltd. Company Overview 27
5.6.1 DuoCure Ltd. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 ElectroCore Inc Company Overview 28
5.7.1 ElectroCore Inc Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 LivaNova PLC Company Overview 33
5.8.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 Medical University of South Carolina Company Overview 42
5.9.1 Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 MicroTransponder Inc Company Overview 43
5.10.1 MicroTransponder Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Nexeon MedSystems Inc Company Overview 48
5.11.1 Nexeon MedSystems Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.12 Otto Bock HealthCare GmbH Company Overview 50
5.12.1 Otto Bock HealthCare GmbH Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Parasym Ltd Company Overview 52
5.13.1 Parasym Ltd Pipeline Products & Ongoing Clinical Trials Overview 52
5.14 Pulsus Medical LLC (Inactive) Company Overview 55
5.14.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55
5.15 Purdue University Company Overview 56
5.15.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 56
5.16 Setpoint Medical Inc Company Overview 57
5.16.1 Setpoint Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 57
5.17 Synergia Medical Company Overview 60
5.17.1 Synergia Medical Pipeline Products & Ongoing Clinical Trials Overview 60
5.18 SzeleSTIM GmbH Company Overview 61
5.18.1 SzeleSTIM GmbH Pipeline Products & Ongoing Clinical Trials Overview 61
5.19 The Feinstein Institute for Medical Research Company Overview 62
5.19.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 62
5.20 Trifectas Medical Corp. Company Overview 67
5.20.1 Trifectas Medical Corp. Pipeline Products & Ongoing Clinical Trials Overview 67
5.21 University of Pittsburgh Company Overview 68
5.21.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview 68
5.22 University of Wisconsin Madison Company Overview 69
5.22.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 69
6 Vagus Nerve Stimulators (VNS)- Recent Developments 70
6.1 Nov 13, 2019: electroCore announces third quarter 2019 financial results 70
6.2 Oct 30, 2019: LivaNova reports third quarter 2019 results 71
6.3 Oct 29, 2019: SetPoint Medical announces oral presentation of results from U.S. pilot study in rheumatoid arthritis patients at American College of Rheumatology (ACR) Annual Meeting 2019 72
6.4 Oct 23, 2019: Study published in Neurology shows chronic epilepsy associated with marker of cardiac electrical instability 72
6.5 Oct 23, 2019: Boston Scientific announces results for third quarter 2019 73
7 Appendix 118
7.1 Methodology 118

and more

https://bisouv.com/